Newsroom | 32885 results

ST. PAUL, Minn.--(BUSINESS WIRE)--Christophe Beck, Ecolab’s chairman and chief executive officer, will address financial analysts at the Baird Global Industrial Conference on Tuesday November 11, 2025. Ecolab will offer a webcast of Mr. Beck’s presentation. Details for the webcast are as follows: TIME: 10:15am CT     DATE : November 11, 2025     DURATION: Approximately 30 minutes     LOCATION: www.ecolab.com/investor     ARCHIVE: A replay of the webcast will be available through February 11, 20...

COLLIERVILLE, Tenn.--(BUSINESS WIRE)--Mueller Industries, Inc. (NYSE: MLI) announced today that its Board of Directors has declared a regular quarterly cash dividend on its common stock of 25 cents per share. The dividend will be payable December 19, 2025 to shareholders of record on December 5, 2025. Mueller Industries, Inc. (NYSE: MLI) is an industrial corporation whose holdings manufacture vital goods for important markets such as air, water, oil and gas distribution; climate comfort; food p...

HOUSTON--(BUSINESS WIRE)--Orion S.A. (NYSE: OEC), a global specialty chemicals company, announced today that Jonathan “Jon” Puckett will succeed Jeff Glajch as chief financial officer, effective Dec. 1, 2025. Puckett brings to Orion more than 30 years of financial leadership experience – much of it within the chemical industry. He joins the company after 14 years with Celanese (NYSE: CE), where he recently served as vice president and CFO for the Acetyl Chain segment. While at Celanese, Puckett...

ASBURY, N.J.--(BUSINESS WIRE)--Asbury Carbons, a leading global supplier of engineered solutions for carbon and graphite materials, announces an upcoming price adjustment on orders shipping on or after January 1, 2026. This adjustment, ranging from 3% to 10% depending on the product, reflects the ongoing inflationary pressures impacting the costs of raw materials, labor, energy, and packaging across the industry. Asbury Carbons has carefully evaluated each product to minimize the impact on cust...

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Announces Third Quarter 2025 Financial Results...

BATAVIA, N.Y.--(BUSINESS WIRE)--Graham Corporation (NYSE: GHM) (“GHM” or “the Company”), a global leader in the design and manufacture of mission-critical fluid, power, heat transfer and vacuum technologies for the Defense, Energy & Process, and Space markets, today announced growing momentum in its commercial space business, supported by a series of recent orders from leading Space/Aerospace customers in aggregate value of approximately $22 million. During its fiscal second and third quart...

美國紐澤西州普林斯頓市--(BUSINESS WIRE)--(美國商業資訊)-- NJ Bio，股份有限公司，一家位於新澤西州普林斯頓的主要契约研究和臨床製造服務提供者，宣佈購買資產並全面整合L2P研究實驗室的研究服務® （“實驗室到藥房”），進一步擴大其服務組合，助力彌合轉化研究領域的鴻溝。 現時，通過1期臨床試驗的生物分子的磨損率非常高，克服這一挑戰的方法是通過轉化研究。 NJ Bio專注於臨床前和早期臨床研究和開發，主要關注ADC、生物偶聯、定制合成、寡核苷酸和mRNAs。 然而，公司此前在向客戶提供系統化轉化研究服務方面仍存在缺口。 通過資產購買和L2P服務的綜合，NJ Bio現在可以在一個傘下提供一套全面的臨床前和轉化研究服務，並將項目從概念驗證無縫地轉移到臨床。 這種方法支持更智慧的數據驅動決策，加快開發進度，改善臨床結果，為客戶的1期及以後項目提供更好的成功機會。 L2P研究實驗室® 其綜合臨床前研發支持，特別是在腫瘤學研究和支持IND應用的服務方面，得到了廣泛認可。 隨著這些服務綜合到NJ Bio的產品中，L2P研究實驗室® , 已停止獨立運營，其臨床前和轉化研究服務組...

SAN FRANCISCO--(BUSINESS WIRE)--IndustrialMind.ai, an AI company founded by former Tesla manufacturing AI leaders, announced a $1.2 M pre-seed round to advance its mission of helping every factory become best-in-class. Investors in the round include Antler, TSVC, Plug and Play, and an angel investor. The funding will accelerate development and customer deployment of IndustrialMind.ai’s “AI Engineer,” with capabilities ranging from drawing-to-process automation to real-time monitoring and root-c...

美国新泽西州普林斯顿--(BUSINESS WIRE)--(美国商业资讯)-- 位于新泽西州普林斯顿的领先合同研究与临床生产服务提供商NJ Bio, Inc.宣布已完成对L2P Research Labs®（“Lab to Pharmacy”） 研究服务资产的收购与全面整合。此次收购将进一步丰富NJ Bio的服务组合，助力弥合转化研究领域的鸿沟。 目前，生物分子在通过I期临床试验后的流失率依然居高不下，而要应对这一挑战，强化转化研究至关重要。NJ Bio长期专注于临床前及早期临床研发，重点领域涵盖抗体偶联药物（ADCs）、生物偶联、定制合成、寡核苷酸及信使RNA（mRNA）等。然而，公司此前在向客户提供系统化转化研究服务方面仍存在缺口。通过此次对L2P服务的资产收购与整合，NJ Bio现已能够在同一平台下提供完整的临床前与转化研究一体化服务，使研发项目得以顺畅衔接，从概念验证阶段无缝推进至临床试验。此举不仅支持更智能、数据驱动的决策，加速研发进程，提升临床成果，还将显著增强客户I期及后续研发项目的成功率。 L2P Research Labs®以其一体化的临床前研发支持能力享有盛誉，尤其...

PRINCETON, New Jersey--(BUSINESS WIRE)--NJ Bio, Inc., un leader nel settore dei servizi di ricerca su contratto e di produzione clinica con sede a Princeton, New Jersey, ha annunciato l’acquisizione e la piena integrazione delle attività di ricerca L2P Research Labs® (“Lab to Pharmacy”), ampliando ulteriormente il proprio portafoglio di servizi e colmando il divario nella ricerca traslazionale. Attualmente il tasso di abbandono delle molecole biologiche oltre la fase 1 delle sperimentazioni cli...